GREM2 and meningioma: GREM2 expression and localization were examined in clinical samples, and GREM2 was found to be almost completely absent in grade 2.3 meningioma by immunostaining, but was strongly expressed around psammoma bodies and at sites of whorl formation grade 1 meningiomas (Fig. 2a).